“…In the United States, marked decreases in prevalence among younger, vaccinated foreign‐born U.S. residents have been observed, most likely as a result of infant immunization programs globally 4. However, the rate of liver cancer deaths in the United States continues to be highest among Asians/Pacific Islanders, reflecting the high prevalence of chronic hepatitis B in this population 30, 31. Globally, other regions with HBsAg prevalence of 2% or greater also have identified high levels of HBV‐associated hepatocellular carcinoma (HCC) 32, 33…”